SÜSS MicroTec (SMHN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
6 Oct, 2026Business and portfolio
Semiconductor front-end and advanced-backend technology provider with a 75-year innovation and growth track record; global customer base, with the largest share of business in Asia.
Two focused segments: Photomask Solutions and Advanced Backend Solutions, spanning cleaning, coating, imaging and bonding processes.
Portfolio covers temporary, permanent and hybrid bonding; positioned as a market leader in temporary bonding and debonding.
GT200 launches as a 200 mm wafer-cleaning platform combining patented technologies with hybrid single-wafer and bath cleaning.
€45m planned investment in a Karlsruhe application and development center through 2028; R&D and application activities are to relocate there.
H1 and Q2 2026 performance
H1 order intake €410.0m, up 145.8% YoY; sales €202.8m, down 23.9% YoY.
H1 gross profit margin 37.2%, down 0.8% YoY; EBIT margin 7.0%, down 9.5 pp YoY.
Q2 order intake €260.7m and sales €116.2m; gross profit margin 38.0% and EBIT margin 9.0%.
Q2 sales and profitability were higher than Q1; prior-year figures were adjusted.
2026 outlook
FY2026 guidance: sales €425–485m, gross profit margin 35–37%, and EBIT margin 8–10%; FY2025 actuals were €503.2m, 35.7% and 13.1%, respectively.
2026 is expected to be a transition year, with lower sales reducing fixed-cost coverage and higher R&D expenses pressuring EBIT margin; gross profit margin is expected to remain broadly stable.
Latest events from SÜSS MicroTec
- Record orders and strong margins support robust growth outlook through 2027 and beyond.SMHN
Industrial Technology Online Investor Conference - Record order intake and strong order book offset lower H1 sales, supporting 2026 guidance.SMHN
Q2 2026 - Strong order intake and innovation drive ambitious growth and margin targets for 2030.SMHN
Investor presentation - Record Q1 order intake drives optimism for 2026 despite weak sales and profit.SMHN
Q1 2026 - Record 2025 sales and new product launches support ambitious 2030 growth targets.SMHN
German Select VII Conference - Record 2025 sales and strategic investments set the stage for double-digit growth through 2030.SMHN
Investor presentation - Revenue set to double by 2030, fueled by innovation, service growth, and margin expansion.SMHN
CMD 2025 - Sales up 45.6%, EBIT margin 15.6%, and guidance raised after strong order intake.SMHN
Q2 2024 - Record sales and profitability in 2024 set a strong outlook for 2025.SMHN
Q4 2024